For Moderate to Severe acne, CAB gel turns out to be effective treatment suggests a study published in the Journal of Drugs ...

Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...

Bausch Health (BHC) announced that CABTREO gel 1.2% w/w, 0.15% w/w and 3.1% w/w, a new triple-combination topical prescription treatment for ...

Dare Bioscience Inc (DARE) secures significant funding and progresses with FDA interactions, despite facing increased ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...

In addition to the continued commercialization by our collaborator Organon of XACIATO™ (clindamycin phosphate) vaginal gel 2%, the first FDA-approved product to emerge from our portfolio and a ...

Topical antibiotics available for treating acne include clindamycin (1% gel, lotion ... must have hematologic monitoring. A glucose-6-phosphate dehydrogenase level must be normal before beginning ...

She also notes that sarecycline has less effect on the gut than other oral antibiotics, such as clindamycin phosphate ... a doctor may prescribe a gel or cream called Tazorac.

Layton; Chief Accounting Officer; Dare Bioscience Inc. Sabrina Johnson; President, Chief Executive Officer, Secretary, Director; Dare Bioscience Inc. C ...

As of the date of this press release, the commercial assets in XOMA Royalty’s milestone and royalty portfolio are VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafenib), MIPLYFFA™ (arimoclomol), XACIATO™ ...